News

MSU professor honing genetic scalpel with backing of biotech company

A Montana State University professor of microbiology and immunology has received funding to fine-tune a revolutionary method to treat genetic disorders.

Blake Wiedenheft, assistant professor in MSU’s Department of Microbiology and Immunology in the College of Agriculture and the College of Letters & Science, will receive $440,000 from California-based biopharmaceutical company Amgen. The funding will flow through SurGene, a biotech company Wiedenheft founded in December 2016 after Amgen expressed an interest in funding his research through a startup company.

Troy Carter, TechLink Staff Writer via the MSU News Service

http://www.montana.edu/news/17560

Posted in:

News Catrgory Sponspor:


TechLink helps the Department of Defense to commercialize leading-edge new technology by partnering DoD labs with private sector companies for technology licensing, transfer, and research and development

Leave a Comment

You must be logged in to post a comment.